Nakamori, Masahiro
Hosomi, Naohisa http://orcid.org/0000-0001-7486-9700
Imamura, Eiji
Matsushima, Hayato
Maetani, Yuta
Yoshida, Mitsuyoshi
Yoshikawa, Mineka
Takeda, Chiho
Nagasaki, Toshikazu
Masuda, Shin
Kayashita, Jun
Tsuga, Kazuhiro
Tanimoto, Keiji
Wakabayashi, Shinichi
Maruyama, Hirofumi
Funding for this research was provided by:
Japan Society for the Promotion of Science (18K10746)
Article History
Received: 25 July 2020
Revised: 20 September 2020
Accepted: 22 September 2020
First Online: 26 September 2020
Compliance with ethical standards
:
: Hirofumi Maruyama reports research support from Eisai, Pfizer, Takeda Pharmaceutical, Otsuka Pharmaceutical, Nihon Pharmaceutical, Shionogi, Teijin Pharma, Fuji Film, Boehringer Ingelheim, Sumitomo Dainippon Pharma, Nihon Medi-Physics, Bayer, MSD, Daiichi Sankyo, Kyowa Hakko Kirin, Sanofi, Novartis, Kowa Pharmaceutical, Astellas Pharma, Tsumura, Japan Blood Products Organization, Mitsubishi Tanabe Pharma, Mylan, which are unrelated to the submitted work. All other authors declare that they have no conflicts of interest.
: The study protocols were approved by the ethics committee of Suiseikai Kajikawa Hospital and were in accordance with the guidelines of the national government based on the Helsinki Declaration of 1964.
: Written informed consent was obtained from all patients or their relatives. All data analyses were blinded.